JOURNEY MEDICAL CORP (DERM)

US48115J1097 - Common Stock

3.89  +0.2 (+5.42%)

Premarket: 3.9 +0.01 (+0.26%)

News Image
2 days ago - Chartmill

These stocks are moving in today's session

Let's have a look at the top gainers and losers one hour before the close of the markets of today's session.

News Image
2 days ago - Chartmill

Let's take a look at the stocks that are in motion in today's session.

Let's have a look at the top gainers and losers in the middle of the day of today's session.

News Image
6 days ago - InvestorPlace

DERM Stock Earnings: Journey Medical Beats EPS, Beats Revenue for Q4 2023

DERM stock results show that Journey Medical beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023.

News Image
6 days ago - BusinessInsider

DERM Stock Earnings: Journey Medical Beats EPS, Beats Revenue for Q4 2023

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Journey Medical (NASDAQ:DERM) just reported results for the fourth quarter of 2...

News Image
7 days ago - Journey Medical Corporation

Journey Medical Corporation Reports Full-Year 2023 Financial Results and Recent Corporate Highlights

Company generated total revenues of $79.2 million for the full year ended December 31, 2023, a 7% increase from the $73.7 million reported in 2022 ...

News Image
10 days ago - Journey Medical Corporation

Journey Medical Corporation Announces U.S. FDA Acceptance of New Drug Application for DFD-29 for the Treatment of Rosacea

Prescription Drug User Fee Act (“PDUFA”) goal date of November 4, 2024...

News Image
13 days ago - Journey Medical Corporation

Journey Medical Corporation to Announce Year End 2023 Financial Results on March 21, 2024

Company to host conference call to discuss financial results and provide a corporate update on March 21, 2024 at 4:30 p.m. ET...

News Image
15 days ago - Journey Medical Corporation

Journey Medical Corporation to Participate in the 36th Annual ROTH Conference

SCOTTSDALE, Ariz., March 13, 2024 (GLOBE NEWSWIRE) -- Journey Medical Corporation (“Journey Medical”) (Nasdaq: DERM), a commercial-stage pharmaceutical...

News Image
17 days ago - Journey Medical Corporation

Journey Medical Corporation Announces Presentation of Data from Phase 1 Clinical Trial Assessing the Impact of DFD-29 (Minocycline Hydrochloride Modified Release Capsules, 40 mg) on Microbial Flora of Healthy Adults at 2024 AAD Annual Meeting

Clinical trial achieved all three primary objectives and subjects completed 16-week treatment with no significant safety issues Results indicate that...

News Image
3 months ago - Seeking Alpha

Journey Medical submits NDA for DFD-29 for rosacea (NASDAQ:DERM)

Journey Medical (FBIO) said it has submitted a New Drug Application for its rosacea treatment DFD-29. The product is being developed with Dr. Reddy's (RDY). Read more here.

News Image
3 months ago - Journey Medical Corporation

Journey Medical Corporation Submits New Drug Application to FDA for DFD-29 to Treat Rosacea

If approved, DFD-29 has potential to be best-in-class and the only oral medication to address both inflammatory lesions and erythema (redness) from rosacea...

News Image
3 months ago - Seeking Alpha

Journey Medical secures credit facility for up to $20M (NASDAQ:DERM)

Journey Medical secures credit facility with SWK Holdings, allowing for borrowings of up to $20M to fund corporate operations and product development.

News Image
3 months ago - Journey Medical Corporation

Journey Medical Corporation Secures Credit Facility with SWK Holdings for up to $20 Million

Provides additional capital for general corporate purposes including funding to support the potential launch of DFD-29...

News Image
4 months ago - Journey Medical Corporation

Journey Medical Corporation Announces Successful Completion of Pre-NDA Meeting with the FDA for DFD-29 to Treat Rosacea

On track to submit a New Drug Application to the FDA for DFD-29 around year-end of 2023...

News Image
5 months ago - Journey Medical Corporation

Journey Medical Corporation Reports Third Quarter 2023 Financial Results and Recent Corporate Highlights

Company generated total net revenues of $34.5 million in the third quarter of 2023, a 101% increase from $17.2 million in the second quarter of 2023 GAAP...

News Image
5 months ago - Journey Medical Corporation

Journey Medical Corporation to Announce Third Quarter 2023 Financial Results on November 7, 2023

Company to host conference call to discuss financial results and provide a corporate update on November 7, 2023 at 4:30 p.m. ET...

News Image
5 months ago - Journey Medical Corporation

Journey Medical Corporation Announces Data from Bioavailability Study of DFD-29 (Minocycline Hydrochloride Modified Release Capsules, 40 mg) vs. Solodyn® (Minocycline Hydrochloride Extended-Release Tablets, 105 mg)

Study demonstrated systemic exposure of DFD-29 was significantly lower than that of Solodyn (105 mg) Data presented at 43rd Annual Fall Clinical...

News Image
5 months ago - Seeking Alpha

Journey Medical says Smith buys 33K shares in co (NASDAQ:DERM)

Justin Smith, an insider at Journey Medical, purchased 33K shares at $2.98 per share. Net purchase activity in the past three months is 289.1K shares.

News Image
6 months ago - Seeking Alpha

Journey Medical director Paley buys 15k shares - filing (NASDAQ:DERM)

Journey Medical director discloses purchase of 15K shares worth $44.7K in recent SEC filing, alongside 8 open market buys and 2 seller trades.

News Image
7 months ago - Journey Medical Corporation

Journey Medical Corporation Enters into an Exclusive License Agreement with Maruho Co., Ltd. for Qbrexza® in South Korea and Other Asian Nations

Journey to receive an upfront payment of $19 million...

News Image
8 months ago - Journey Medical Corporation

Journey Medical Corporation Reports Second Quarter 2023 Financial Results and Recent Corporate Highlights

The Company generated total net revenues of $17.2 million in the second quarter of 2023, a 41% increase from $12.2 million in the first quarter of 2023 ...

News Image
8 months ago - Journey Medical Corporation

Journey Medical Corporation to Announce Second Quarter 2023 Financial Results on August 8, 2023

Company to host conference call to discuss financial results and provide a corporate update on August 8, 2023 at 4:30 p.m. ET Company and Neal Bhatia, MD,...

News Image
8 months ago - Journey Medical Corporation

Journey Medical Corporation to Announce Second Quarter 2023 Financial Results the Week of August 7, 2023

Company to host conference call to discuss financial results and provide a corporate update the week of August 7, 2023...